
BOSTON (WHN) – An amateur athlete, aged 21, has documented his current performance-enhancement regimen as he prepares for a debut in the International Federation of Bodybuilding and Fitness (IFBB) Classic Physique division later this year. The individual, who identifies as a carpenter and aspiring coach, has been training for approximately 5.5 years, with the last 1.5 years involving the use of anabolic agents.
This individual’s logged training and nutritional data, shared on a public platform, offers a glimpse into the practices of some aspiring competitors. He reports transitioning to enhanced training approximately 1.5 years prior to this current logging period. His stated goal is to compete in “season c” of the IFBB circuit in 2025.
The athlete’s current cycle, detailed in his log, includes Testosterone Enanthate at 400mg per week, Primobolan at 600mg per week, and Nandrolone Decanoate at 200mg per week. He is also utilizing Human Growth Hormone (GH) at 4 IU daily, Lantus (insulin glargine) at 20 IU, and Nova Rapid (insulin aspart) at 3 IU on “high days,” which are specified as three days per week.
Nutritional intake is stratified across different training days. On “high days,” his reported macronutrient targets are 250 grams of protein, 1005 grams of carbohydrates, and zero added fats. For “medium days,” occurring twice weekly, these targets shift to 250 grams of protein, 825 grams of carbohydrates, and 50 grams of added fats. On rest days, twice weekly, his macros are listed as 250 grams of protein, 300 grams of carbohydrates, and 70 grams of added fats.
His training split involves a six-day schedule: Monday for legs, Tuesday for chest and arms, Thursday for back and deltoids, Friday for arms and hamstrings, and Saturday for chest and calves. Wednesdays and Sundays are designated as rest days.
Regarding past cycles, the athlete states his first was approximately one month after a natural competition in 2023. That initial regimen reportedly consisted of testosterone and Nandrolone Phenylpropionate (NPP), along with insulin, for an estimated 12-15 weeks. Following this, he described a “health phase” before resuming growth with similar compounds. He claims to have gained approximately 15 kilograms of lean tissue within that year of intensified growth.
The athlete is reportedly sponsored by “Raptor Labs,” a company whose products he intends to use throughout his growth phase, preparation, and the foreseeable future. He expressed gratitude for their support toward his competitive objectives.
This individual’s progress log, initiated in 2025, includes physique updates shared on Saturdays. He plans to provide further updates on training and check-ins throughout the week. The information presented reflects a personal account of an athlete’s self-directed regimen, rather than findings from peer-reviewed scientific research. The use of anabolic-androgenic steroids, growth hormone, and insulin carries significant health risks, including cardiovascular issues, metabolic dysfunction, and endocrine disruption, which are not detailed within the provided log.